Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
Date:8/9/2012

uced CNS Side Effects", Gursahani, H., et al. 
  • Poster Session 081:  "Mechanisms of Neuropathic Pain: Ion Channels"
  • Date: October 13, 2012, 1:00 p.m. — 5:00 p.m. Central Time
  • Abstract Title: "Preclinical Pharmacology of Mu Opioids — A Comparison of Morphine, Oxycodone, Hydrocodone and Fentanyl in Rodent Pain Models", Choi, I., et al. 
  • Poster Session 882:  "Opioid Pharmacology and Other Analgesics"
  • Date: October 17, 2012, 1:00 p.m. — 5:00 p.m. Central Time

    • American Association of Pharmaceutical Scientists (AAPS), Chicago, IL

  • Abstract Title: "Interspecies Comparison of Pharmacokinetics of the Novel Opioid Analgesic NKTR-181", Odinecs, A., et al. 
  • Meeting Dates: October 14-18, 2012

    • Conference Call to Discuss Second Quarter 2012 Financial ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT) today, Thursday, August 9, 2012.

    The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Sunday, September 9, 2012.

    To access the conference call, follow these instructions:

    Dial: (866) 761-0749 (U.S.); (617) 614-2707 (international)
    Passcode: 68434730 (Nektar Therapeutics is the host)

    An audio replay will also be available shortly following the call through Sunday, September 9, 2012 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 80503060.

    In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, o
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
    2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
    3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
    4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
    5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
    6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
    7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
    8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... that it will present at the Deutsche Bank 38 th ... at 10:40 a.m. (ET). A live webcast ... website at www.bd.com/investors and will be available for ... BD BD is a leading global medical technology ...
    (Date:5/24/2013)... -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading ... Dr. Robert Grieve , the Company,s chairman ... , executive vice president and chief financial officer, will present ... held May 30, 2013 in New York City ... The Company,s presentation is scheduled to begin at 1:30 p.m. ...
    (Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
    Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
    ... DecisionView Inc., a leading provider of ... life sciences companies, today announced the release of ... flagship solution for patient enrollment planning, tracking and ... into site performance and cost projections, StudyOptimizer 4.3 ...
    ... 19, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
    Cached Medicine Technology:DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 2DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 3North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6
    (Date:5/25/2013)... 25 (HealthDay News) -- Animals make great companions for senior ... in the car are far more likely to crash than ... The new study included 2,000 licensed drivers aged 70 ... asked how often they drove with their pet in the ... the crash risk was twice as high as among those ...
    (Date:5/25/2013)... Studies from Johns Hopkins University reveal a direct ... their inability to get adequate sleep. These same studies ... relieve many symptoms. , Johns Hopkins University School ... significantly associated with overall weight loss, especially belly fat. ... 6th, 2012, researchers monitored 77 participants who were diabetic ...
    (Date:5/25/2013)... May 25, 2013 On May 20, 2013 ... do not wish to discuss or plan for their eventual ... FuneralFinancials.com released a Must-Do List to help people ... Financials recommends, “Creating a personal fact sheet.” , While not ... financial information and personal data. It may include a ...
    (Date:5/25/2013)... By working diligently for months on ... of the 2012 Lamborghini Aventador into their well-built fitments ... in the list of vehicles lined by SizeItUp for ... set to thrill automobile lovers in the year 2013. ... looks, the 2012 Lamborghini Aventador comes with extraordinarily spacious ...
    (Date:5/25/2013)... Many orthodontists have thought about moving their office ... is. Most people would naturally assume that the ... cloud service and support would own and maintain all ... they'd be wrong. Cloud providers lease space in ... that houses servers and related equipment to run cloud ...
    Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
    ... School of Public Health (HSPH) have found that children ... laws promoting smoke-free public places have significantly lower levels ... those living in counties with no smoke-free laws. ... with smoke-free laws had 39% lower prevalence of cotinine ...
    ... June 5 Patients undergoing treatment for melanoma that ... chemotherapy delivered directly into the liver,s blood vessels, according ... and Delcath Systems Inc., and led by James F. ... School of Medicine, and surgical oncologist with UPMC Cancer ...
    ... Studies show combo chemotherapy, new drug prolonged lives of ... News) -- Researchers report they prolonged survival for some ... the median survival is currently only about six months. ... called crizotinib shrank tumors in the majority of lung ...
    ... millions in hopes of protection against cancer and a host ... in reducing a patient,s risk of developing lung cancer - ... of an international Phase III clinical trial. Results from ... were presented today at the American Society of Clinical Oncology ...
    ... ... J. Brueck MD FACS, Fort Myers cosmetic surgeon, has applied stem cell therapy ... exist in a person’s fat. It can be harvested and spun down. It ... PRP is the result of the blood being spun down to create a ...
    ... ... the Savory Institute and the Africa Centre for Holistic Management are winning awards for their ... rivers back to life, increase food production and security and store carbon in ever deeper ... (PRWEB) ...
    Cached Medicine News:Health News:Smoke-free air laws effective at protecting children from secondhand smoke 2Health News:New treatment method safe, effective for advanced melanoma patients 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Selenium shows no benefit in prevention of lung cancer 2Health News:Selenium shows no benefit in prevention of lung cancer 3Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 2Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 3Health News:Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change. 2
    ... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
    ... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
    ... a layered design unique in the industry. ... prevent stray electrosurgical burns along the shaft ... or capacitive coupling; a well-documented patient safety ... AEM Instruments provides a neutral return path ...
    ... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
    Medicine Products: